183 related articles for article (PubMed ID: 33227375)
1. On the particle formation of leucine in spray drying of inhalable microparticles.
Ordoubadi M; Gregson FKA; Wang H; Nicholas M; Gracin S; Lechuga-Ballesteros D; Reid JP; Finlay WH; Vehring R
Int J Pharm; 2021 Jan; 592():120102. PubMed ID: 33227375
[TBL] [Abstract][Full Text] [Related]
2. Trileucine as a dispersibility enhancer of spray-dried inhalable microparticles.
Ordoubadi M; Gregson FKA; Wang H; Carrigy NB; Nicholas M; Gracin S; Lechuga-Ballesteros D; Reid JP; Finlay WH; Vehring R
J Control Release; 2021 Aug; 336():522-536. PubMed ID: 34229002
[TBL] [Abstract][Full Text] [Related]
3. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
Wang Z; Wang H; Vehring R
Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968
[TBL] [Abstract][Full Text] [Related]
4. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics.
Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Vehring R
Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
Li X; Mansour HM
AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
[TBL] [Abstract][Full Text] [Related]
6. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
7. Relationship between surface concentration of L-leucine and bulk powder properties in spray dried formulations.
Mangal S; Meiser F; Tan G; Gengenbach T; Denman J; Rowles MR; Larson I; Morton DA
Eur J Pharm Biopharm; 2015 Aug; 94():160-9. PubMed ID: 26007290
[TBL] [Abstract][Full Text] [Related]
8. Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique.
Bahrainian S; Mirmoeini MS; Gilani Z; Gilani K
Eur J Pharm Sci; 2021 Dec; 167():106008. PubMed ID: 34530077
[TBL] [Abstract][Full Text] [Related]
9. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
10. The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin.
Barazesh A; Gilani K; Rouini M; Barghi MA
Daru; 2020 Jun; 28(1):75-85. PubMed ID: 31808069
[TBL] [Abstract][Full Text] [Related]
11. Multi-Solvent Microdroplet Evaporation: Modeling and Measurement of Spray-Drying Kinetics with Inhalable Pharmaceutics.
Ordoubadi M; Gregson FKA; Melhem O; Barona D; Miles REH; D'Sa D; Gracin S; Lechuga-Ballesteros D; Reid JP; Finlay WH; Vehring R
Pharm Res; 2019 May; 36(7):100. PubMed ID: 31089892
[TBL] [Abstract][Full Text] [Related]
12. A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.
Focaroli S; Mah PT; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
Int J Pharm; 2019 May; 562():228-240. PubMed ID: 30849470
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
Wang J; Kutter JP; Mu H; Moodley A; Yang M
Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
[TBL] [Abstract][Full Text] [Related]
14. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Lu W; Rades T; Rantanen J; Yang M
Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
[TBL] [Abstract][Full Text] [Related]
15. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
[TBL] [Abstract][Full Text] [Related]
16. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.
Mah PT; O'Connell P; Focaroli S; Lundy R; O'Mahony TF; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
Eur J Pharm Biopharm; 2019 Nov; 144():139-153. PubMed ID: 31536784
[TBL] [Abstract][Full Text] [Related]
17. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
[TBL] [Abstract][Full Text] [Related]
18. Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration.
Sou T; Morton DA; Williamson M; Meeusen EN; Kaminskas LM; McIntosh MP
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):361-71. PubMed ID: 25714115
[TBL] [Abstract][Full Text] [Related]
19. Lipid-microparticles for pulmonary delivery of active pharmaceutical ingredients: Impact of lipid crystallization on spray-drying processability.
Corzo C; Fuchsbichler A; Savencu I; Afonso Urich J; Zimmer A; Lochmann D; Reyer S; Salar-Behzadi S
Int J Pharm; 2021 Dec; 610():121259. PubMed ID: 34740761
[TBL] [Abstract][Full Text] [Related]
20. Leucine as an excipient in spray dried powder for inhalation.
Alhajj N; O'Reilly NJ; Cathcart H
Drug Discov Today; 2021 Oct; 26(10):2384-2396. PubMed ID: 33872799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
